The protein expression of SPHK1 and HAS2 was validated by Western blot, and the results showed that the levels of SPHK1 and HAS2 protein were markedly elevated in pancreatic cancer cell lines compared with normal pancreatic duct epithelial cell line (Figure 2(b)). The gene discussed is HAS2; the disease is pancreatic neoplasm.